Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ChimerixNorthwest BiotherapeuticsIMMUTEP LTD/SSavaraZynerba Pharmaceuticals
SymbolNASDAQ:CMRXOTCMKTS:NWBONASDAQ:IMMPNASDAQ:SVRANASDAQ:ZYNE
Price Information
Current Price$1.33$0.16$0.67$1.80$3.31
52 Week RangeBuyN/ABuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyN/ABuyBuyBuy
Consensus Price Target$5.00N/A$4.00$8.60$17.83
% Upside from Price Target275.94% upsideN/A497.01% upside377.78% upside438.77% upside
Trade Information
Market Cap$84.58 million$104.21 million$28.08 million$94.56 million$81.74 million
Beta1.281.312.090.953.54
Average Volume508,6681,388,675563,961359,764538,080
Sales & Book Value
Annual Revenue$12.52 million$2.41 million$5.36 millionN/A$90,000.00
Price / Sales6.5642.864.88N/A866.48
CashflowN/AN/AN/A$4.86 per shareN/A
Price / CashN/AN/AN/A0.37N/A
Book Value$1.79 per share($0.07) per share$0.51 per share$2.47 per share$3.26 per share
Price / Book0.74-2.241.31N/A1.02
Profitability
Net Income$-112,580,000.00$-20,300,000.00$-13,120,000.00$-78,170,000.00$-32,940,000.00
EPS($0.86)N/AN/A$4.57($1.50)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/A∞∞N/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-899.68%-842.16%N/AN/AN/A
Return on Equity (ROE)-35.56%N/AN/A-48.52%-41.94%
Return on Assets (ROA)-32.34%-138.90%N/A-35.86%-37.31%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.29%0.23%N/A
Current Ratio12.80%0.08%6.77%11.40%7.22%
Quick Ratio12.80%0.08%N/A11.40%7.22%
Ownership Information
Institutional Ownership Percentage51.03%0.03%0.30%40.87%45.61%
Insider Ownership Percentage9.40%27.80%N/A6.50%10.79%
Miscellaneous
Employees8214N/AN/A25
Shares Outstanding61.74 million660.01 million39.00 million50.84 million23.56 million
Next Earnings Date5/14/2020 (Estimated)5/8/2020 (Estimated)N/A5/14/2020 (Estimated)5/13/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableOptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel